(Q46456759)

22 December 2017

title

CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS. (English)

1 reference

22 December 2017

0 references

1

F Stephen Hodi

1 reference

22 December 2017

author name string

Darryl A Oble

2

1 reference

22 December 2017

Jan Drappatz

3

1 reference

22 December 2017

Elsa F Velazquez

4

1 reference

22 December 2017

Nikhil Ramaiya

5

1 reference

22 December 2017

Naren Ramakrishna

6

1 reference

22 December 2017

Arthur L Day

7

1 reference

22 December 2017

Andrea Kruse

8

1 reference

22 December 2017

Suzanne Mac Rae

9

1 reference

22 December 2017

Axel Hoos

10

1 reference

22 December 2017

Martin Mihm

11

1 reference

22 December 2017

publication date

29 July 2008

1 reference

22 December 2017

Nature Clinical Practice Oncology

published in

1 reference

22 December 2017

volume

5

1 reference

22 December 2017

page(s)

557-561

1 reference

22 December 2017

issue

9

1 reference

22 December 2017

The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

Checkpoint blockade in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

The treatment of brain metastases in melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

CNS immune privilege: hiding in plain sight

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

Management of metastatic melanoma 2005.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1183

7 January 2021

Identifiers

DOI

10.1038/NCPONC1183

1 reference

22 December 2017

PubMed ID

18665147

1 reference

22 December 2017